First interim results from Guinea Ebola vaccine trial suggest high protection
Friday 31 July 2015
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7,500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination,